MADISON WARD: Open Payments
NPI 1518688043 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,007 in 126 payments from 21 companies in 2025. Trend: 2023 $1,298 · 2024 $1,873 · 2025 $2,007
Food & beverage: $2,007
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $370 |
| AstraZeneca Pharmaceuticals LP | 12 | $357 |
| Novo Nordisk Inc | 17 | $292 |
| Lilly USA, LLC | 20 | $208 |
| Amgen Inc. | 12 | $154 |
| PFIZER INC. | 5 | $96 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| Esperion Therapeutics, Inc. | 3 | $49 |
Products named: AIRSUPRA, JARDIANCE, MOUNJARO, QULIPTA, Ozempic, EVENITY, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
